Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
Agency: National Institutes of Health
Assistance Listings: 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Description
The purpose of this notice of funding opportunity (NOFO) is to support rigorous analytical validation of method(s) used for measuring biomarkers for neurological and neuromuscular disorders for use in clinical trials or clinical practice. Applicants must justify the unmet need for the biomarker(s) and measurement methods and specify one or two context(s) of use for the biomarker(s). Activities supported include optimizing and evaluating the accuracy, precision, reportable range, and analytical sensitivity and specificity of the detection method across multiple sites and operators and establishing reference intervals and quality control procedures. Multi-site applications are expected but not required.
Eligibility
Eligible applicants
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Business
- Small businesses
- For-profit organizations other than small businesses
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Government
- County governments
- Federally recognized Native American tribal governments
- State governments
- City or township governments
- Public and Indian housing authorities
- Special district governments
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
| File name | Description | Last updated |
|---|---|---|
| PAR-25-050-Full-Announcement.html | PAR-25-050 Full Announcement Text | Nov 1, 2024 06:58 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/pa-files/PAR-25-050.html
Closing: June 22, 2026
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
PAR-25-050
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
3
Posted date:
October 2, 2024
Archive date:
July 22, 2026
